A Study of the Efficiency of Topiramate in Patients with Epilepsy
Enxiang Tao
Abstract
Enxiang Tao
Abstract
Objective: TO observe and evaluate the clinical efficiency and safety of topiramate for treatment of patients with various types of epilepsy. Methods: 105 patients suffering from epilepsy were treated with topiramate, of them 72 cases received a topiramate add-on therapy and 33 cases a monotherapy. The efficiency and side effects were evaluated after 8 weeks titration period and 12 weeks stabilization period. Results: The total effective rate was 72.2%and 84.8% in add-on group and monotherapy group respectively. The seizure free rate was 27.8% and 45.5% in two groups respectively.Side effects were generally mild. Conclusions: Topiramate is a highly effective and safe antiepileptic drug.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: TO observe and evaluate the clinical efficiency and safety of topiramate for treatment of patients with various types of epilepsy. Methods: 105 patients suffering from epilepsy were treated with topiramate, of them 72 cases received a topiramate add-on therapy and 33 cases a monotherapy. The efficiency and side effects were evaluated after 8 weeks titration period and 12 weeks stabilization period. Results: The total effective rate was 72.2%and 84.8% in add-on group and monotherapy group respectively. The seizure free rate was 27.8% and 45.5% in two groups respectively.Side effects were generally mild. Conclusions: Topiramate is a highly effective and safe antiepileptic drug.
Key concepts: Topiramate, Medicine, Epilepsy, Antiepileptic drug, Anesthesia, Clinical efficacy, Side effect (computer science), Surgery